Shenzhen - Delayed Quote CNY

Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ)

16.84 +0.45 (+2.75%)

At close: October 30 at 3:04:18 PM GMT+8

Chart Range Bar

Loading chart for 000623.SZ

Previous Close 16.39
Open 16.63
Bid 16.86 x --
Ask 16.87 x --
Day's Range 16.50 - 17.07
52 Week Range 16.36 - 21.94
Volume 20,741,718
Avg. Volume 10,337,894
Market Cap (intraday) 20.139B
Beta (5Y Monthly) 0.53
PE Ratio (TTM) 6.08
EPS (TTM) 2.77
Earnings Date --
Forward Dividend & Yield 0.50 (3.05%)
Ex-Dividend Date Oct 23, 2026
1y Target Est --

Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Dunhua, China.

www.jlaod.com

5,461

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000623.SZ

11.26%

SSE Composite Index (000001.SS)

9.32%

1-Year Return

000623.SZ

19.73%

SSE Composite Index (000001.SS)

9.73%

3-Year Return

000623.SZ

13.32%

SSE Composite Index (000001.SS)

19.11%

5-Year Return

000623.SZ

23.83%

SSE Composite Index (000001.SS)

1.46%

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

133.71%
Return on Assets (ttm)

-0.20%
Return on Equity (ttm)

9.30%
Revenue (ttm)

2.24B
Net Income Avi to Common (ttm)

2.99B
Diluted EPS (ttm)

2.77

Balance Sheet and Cash Flow

Total Cash (mrq)

3.08B
Total Debt/Equity (mrq)

6.38%
Levered Free Cash Flow (ttm)

-104.83M

000538.SZ Yunnan Baiyao Group Co.,Ltd

53.71 +1.47%

000423.SZ Dong-E-E-Jiao Co., Ltd.

47.93 +1.27%

000069.SZ Shenzhen Overseas Chinese Town Co.,Ltd.

1.6300 -1.21%

000630.SZ Tongling Nonferrous Metals Group Co.,Ltd.

4.8300 -1.43%

000402.SZ Financial Street Holdings Co., Ltd.

2.1500 -0.46%

U.S. markets closed

Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ)

-0.30%

-3.27%

-10.76%

-13.77%

-22.00%

6.38%

1,098.72%

Jilin Aodong Pharmaceutical Group Co., Ltd. Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch